Pulsecath and Terumo Europe signed com­bin­ing tech­nolo­gies and dis­tri­b­u­tion agree­ments

On April 20th 2015 both par­ties signed agree­ments that com­bine Terumo’s Solopath expand­able sheath with Pulsecath’s iVAC 2L per­cu­ta­neous short term pul­satile LVAD.
The Solopath SR-19/35 expand and re-col­lapsi­ble Sheath will be merged with iVAC 2L as 13.5 Fr. reli­able and easy to use intro­duc­ing sys­tem. This tech­nolo­gies com­bi­na­tion will cre­ate an attrac­tive full per­cu­ta­neous short term pul­satile LVAD to use in CathLabs with high risk PCI and car­dio­genic shock patients.
As part of these agree­ments Terumo Europe will dis­trib­ute, ser­vice and sup­port the iVAC 2L in four European coun­tries: Italy , Spain , Switzerland and France.
Both com­pa­nies are going to launch this cor­po­ra­tion dur­ing the PCR con­gress, Paris May 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *